1. Home
  2. LEGT vs RNAC Comparison

LEGT vs RNAC Comparison

Compare LEGT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGT
  • RNAC
  • Stock Information
  • Founded
  • LEGT 2023
  • RNAC 2007
  • Country
  • LEGT United States
  • RNAC United States
  • Employees
  • LEGT N/A
  • RNAC N/A
  • Industry
  • LEGT
  • RNAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEGT
  • RNAC Health Care
  • Exchange
  • LEGT Nasdaq
  • RNAC Nasdaq
  • Market Cap
  • LEGT 277.1M
  • RNAC 316.1M
  • IPO Year
  • LEGT 2024
  • RNAC 2016
  • Fundamental
  • Price
  • LEGT $10.74
  • RNAC $13.33
  • Analyst Decision
  • LEGT
  • RNAC Strong Buy
  • Analyst Count
  • LEGT 0
  • RNAC 5
  • Target Price
  • LEGT N/A
  • RNAC $40.00
  • AVG Volume (30 Days)
  • LEGT 10.9K
  • RNAC 83.7K
  • Earning Date
  • LEGT 01-01-0001
  • RNAC 08-07-2025
  • Dividend Yield
  • LEGT N/A
  • RNAC N/A
  • EPS Growth
  • LEGT N/A
  • RNAC N/A
  • EPS
  • LEGT 0.35
  • RNAC N/A
  • Revenue
  • LEGT N/A
  • RNAC $34,173,000.00
  • Revenue This Year
  • LEGT N/A
  • RNAC N/A
  • Revenue Next Year
  • LEGT N/A
  • RNAC N/A
  • P/E Ratio
  • LEGT $0.88
  • RNAC N/A
  • Revenue Growth
  • LEGT N/A
  • RNAC 31.91
  • 52 Week Low
  • LEGT $10.15
  • RNAC $8.46
  • 52 Week High
  • LEGT $10.86
  • RNAC $26.50
  • Technical
  • Relative Strength Index (RSI)
  • LEGT N/A
  • RNAC 60.40
  • Support Level
  • LEGT N/A
  • RNAC $11.80
  • Resistance Level
  • LEGT N/A
  • RNAC $13.91
  • Average True Range (ATR)
  • LEGT 0.00
  • RNAC 1.10
  • MACD
  • LEGT 0.00
  • RNAC 0.03
  • Stochastic Oscillator
  • LEGT 0.00
  • RNAC 53.04

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: